Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363119930060020192
Korean Journal of Pain
1993 Volume.6 No. 2 p.192 ~ p.198
Clinical Study of Acute and Chronic Pain by the Application of Magentic Resonance Analyser ITM.
¹Ú¿í
ÁøÈñö/Á¶¸íÇö/À±¼®ÁØ/ÀÌÁø½Â/ÀÌÁ¤¼®/ÃÖ¼®È¯/±è¼º¿­
Abstract
In 1984, a magnetic resonance spectrometer (magnetic resonance analyser, MRA ITM) was developed by Sigrid Lipsett and Ronald J. Weinstock in the USA, Biomedical applications of the spectrometer have been examined by Dr. Hoang Van Duc
(pathologist,
USC),
and Nakamura, et al (Japan). From their theoretical views, the biophysical functions of this machine are to analyse and synthesize a healthy tissue and organ resonance pattern, and to detect and correct an abnormal tissue and organ resonance
pattern.
All or the above functions are based on Quantum physics. The healthy tissue and organ resonance patterns are predetermined as standard magnetic resonance patterns by digitizing values based on peak resonance emissions (response levels or high
pitched
echo-sounds amplified via human body).
In clinical practice. a counter or neutralizing resonance pattern calculated by the spectrometer can correct a phase-shifted resonance pattern (response levels or low pitched echo-sounds) of a diseased tissue and organ. By administering the
counter
resonance pattern into the site of pain and trigger point, it is possible to readjust the phase-shifted resonance pattern and then to alleviate pain through regulation of the neurotransmitter function of the nervous system.
For assessing clinical effectiveness of pain relief with MRA ITM, this study was designed to estimate pain intensity by the patient's subjective verbal rating scale (VRS such as graded to no pain, mild, moderated and severe) before application of
it, to
evaluate an amount of pain relief as applied the spectrometer by the patient's subjective pain relief scale (visual analogue scale, VAS, 0~100%), and then to observe a continuation of pain relief following it's application for managing acute and
chronic
pain in the 102 patients during an 8 months period beginning March, 1993.
An application time of the spectrometer ranged from 15 to 30 minutes daily in each patient at or near the site of pain and trigger point when the patient wanted to be treated. The subjects consisted of 54 males and 48 females, with the age
distribution
between 23~40 years in 29 cases, 41~60 years in 48 cases and 61~76 YEARS IN 25 CASES RESPECTIVELY (Table 1). The kinds of diagnosis and the main site of pain, the duration of pain before the application, and the frequency of it's application were
recorded on the Table 2, 3 and 4. A distinction between acute and chronic pain was defined according to both of the pain intervals lasting within and over 3 months.
The results of application of the spectrometer were noted as follows;
In 51 cases of acute pain before the application, the pain intensities were rated mild in 10 cases, moderate in 15 cases and severe in 26 cases. The amounts of pain relief were noted as between 30~50% in 9 cases, 51~70% in 13 cases and 71~95% in
29
cases. The continuation of pain relief appeared between 6~24 hours in two cases, 2~5 days in 10 cases, 6~14 days in 4 cases, 15 days in one case, and completely relived of pain in 34 cases (Table 5~7).
In 51 cases of chronic pain before the application, the pain intensities were rated mild in 12 cases, moderate in 18 cases and sever in 21 cases. The amounts of pain relief were noted as between 0~50% in 10 cases, 51~70% in 27 cases and 71~90% in
14
cases. The continuation of pain relief appeared to have no effect in two cases. The level of effective duration was between 6~12 hours in two cases, 2~5 days in 11 cases, 6~14 days in 14 cases, 15~60 days in 9 cases and in 13 cases the patient
was
completely relieved of pain (Table 5~7). There were no complications in the patients except a mild reddening and tingling sensation fo skin while applying the spectrometer.
Total amounts of pain relief in all of the subjects were accounted as poor and fair in 19 (18.6%) cases, good in 40 (39.2%) cases and excellent in 43 (42.2%) cases. The clinical effectiveness of MRA ITM showed variable distributions from no
improvements
to complete relief of pain by the patient's assesment.
In conclusion, we suggest that MRA ITM may be successful in immediate and continued pain relief but still requires several treatments for continued relief and may be gradually effective in pain relief while being applied regpeatedly.
KEYWORD
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø